Sahasraksha Ayurvedics Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.47 Cr
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 20.49%
- Profit Growth 106.47%
- Ebitda -41.40%
- Net Worth 8.15%
- Total Assets 7.88%
About Sahasraksha Ayurvedics
Sahasraksha Ayurvedics Limited (SAL) is a Public Limited Indian Non-Government Company incorporated in India on 17 March 2010 and has a history of 14 years and ten months. Its registered office is in Mangalore, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lakshmi Narayana, Sapna Jayagovinda, and Jayagovinda Ukkinadka serve as directors at the Company.
Company Details
-
Location
Mangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85191KA2010PLC052862
-
Company No.
052862
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
17 Mar 2010
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sahasraksha Ayurvedics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayagovinda Ukkinadka
|
Managing Director | 17-Mar-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Lakshmi Narayana
|
Director | 17-Mar-2010 | Current |
|
Sapna Jayagovinda
|
Director | 17-Mar-2010 | Current |
Financial Performance of Sahasraksha Ayurvedics.
Sahasraksha Ayurvedics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.49% increase. The company also saw a substantial improvement in profitability, with a 106.47% increase in profit. The company's net worth moved up by a moderate rise of 8.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sahasraksha Ayurvedics?
In 2023, Sahasraksha Ayurvedics had a promoter holding of 75.62% and a public holding of 24.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sahasraksha Ayurvedics?
Unlock and access historical data on people associated with Sahasraksha Ayurvedics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sahasraksha Ayurvedics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sahasraksha Ayurvedics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.